Investor Relations

Our deep industry knowledge and research on best practices enables us to assist each client in crafting key messages. We integrate vision, the value and impact of scientific innovation, differentiation from peers, and specific expertise into narratives that build credibility and value and, importantly, resonate with key external stakeholders: investors, media, and industry thought leaders. We leverage our creative and digital capabilities to amplify company messaging across all interactive channels.

Entrepreneurial life sciences companies compete for attention from the start. Success demands a memorable brand, messaging that is differentiated, persuasive, and scientifically sound, and a strategic, integrated plan to reach the right audiences at the right time. We help companies access the capital, coverage, and connections they need by shaping compelling stories, amplifying them across creative and digital channels, and introducing them to key stakeholders. Every engagement is led by a dedicated, cross-functional team that takes a bespoke, fully integrated approach.

We provide high-touch investor relations support across the full company life cycle, helping clients navigate a variety of financing strategies to access the capital markets. From preparation to execution, we support every stage of the financing process—shaping messaging, building data rooms, identifying and targeting investors, and driving outreach to close successful fundraises. Even in challenging market conditions, our clients continue to secure the capital they need to grow, backed by strategic guidance, strong networks, and deep expertise in investor engagement.

Strategic, well-executed events—whether in-person or virtual—play a critical role in building visibility and credibility across the health care and life sciences ecosystem. We provide support in developing content for and executing everything from traditional analyst and investor R&D days to KOL roundtables and events at medical conferences.

Our premier corporate access event each January in San Francisco is one of the largest in the industry—one of the biggest annual efforts in investor relations—with more than 2,300 meetings hosted for nearly 70 client companies in 2025 alone.

Our team can help you identify and connect with key partners in equity research and investment banking who can drive visibility and enhance market support for your story, while also providing industry intelligence. Leveraging deep knowledge of the health care and biotechnology investment landscape, we help clients target the right bankers and analysts, manage critical relationships, and provide tactical support for outreach, engagement, and scheduling.

To help broaden your shareholder base and strengthen your financial position, we identify, target, and introduce you to the right investors. Our proprietary database adds a qualitative layer, connecting clients to thought leaders, industry heavyweights, small funds, and newly launched funds not captured through traditional quantitative analyses.

All together, we help companies capitalize on buy-side opportunities and benefit from positive and consistent engagement.

Strategic disclosure of clinical, corporate, and financial news is critical to shaping perception and maximizing impact. Through coordinated efforts, we help companies broaden their visibility by developing strong collateral materials and leveraging key newsflow—from earnings updates and clinical milestones to analyst days, KOL events, and medical meetings—to strengthen engagement with investors and analysts at every step.